Literature DB >> 3261391

Homology of perforin to the ninth component of complement (C9).

Y Shinkai1, K Takio, K Okumura.   

Abstract

Perforin is one of the cytolytic factors present in the cytoplasmic granules of mouse cytotoxic T lymphocytes and natural killer cells. We have determined the sequence of the N-terminal amino acids of perforin purified from a mouse natural killer cell line, and, by using oligonucleotide probes corresponding to the amino acid residues, we have identified a complementary DNA encoding perforin from the cDNA library of a mouse cytotoxic T lymphocyte clone. As predicted from the functional similarities between perforin and the ninth component of the serum cytolytic system, complement (C9) (refs 4-8), the deduced primary structure of perforin has homology with C9 at their respective functionally conserved regions. We find that perforin is only expressed in killer cell lines, and not in helper T lymphocytes or other tumour cells tested. Thus we have provided direct molecular evidence that a killer-cell-specific protein evolutionally linked to C9 is involved in cell-mediated cytolysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3261391     DOI: 10.1038/334525a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  62 in total

1.  Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin.

Authors:  K A Browne; E Blink; V R Sutton; C J Froelich; D A Jans; J A Trapani
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

2.  Change in perforin-positive peripheral blood lymphocyte (PBL) subpopulations following exercise.

Authors:  R Staats; S Balkow; S Sorichter; H Northoff; H Matthys; W Luttmann; A Berg; J C Virchow
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

Review 3.  Perforin and its role in T lymphocyte-mediated cytolysis.

Authors:  B Lowin; O Krähenbühl; C Müller; M Dupuis; J Tschopp
Journal:  Experientia       Date:  1992-10-15

4.  Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC).

Authors:  Alexander E Aleshin; Ingrid U Schraufstatter; Boguslaw Stec; Laurie A Bankston; Robert C Liddington; Richard G DiScipio
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

5.  Complement pore genesis observed in erythrocyte membranes by fluorescence microscopic single-channel recording.

Authors:  H Sauer; L Pratsch; G Fritzsch; S Bhakdi; R Peters
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

6.  Cytolytic and ion channel-forming properties of the N terminus of lymphocyte perforin.

Authors:  D M Ojcius; P M Persechini; L M Zheng; P C Notaroberto; S C Adeodato; J D Young
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Structural analysis of the uEGF gene in the sea urchin strongylocentrotus purpuratus reveals more similarity to vertebrate than to invertebrate genes with EGF-like repeats.

Authors:  M G Delgadillo-Reynoso; D R Rollo; D A Hursh; R A Raff
Journal:  J Mol Evol       Date:  1989-10       Impact factor: 2.395

8.  Inhibition of intracellular bacterial replication in fibroblasts is dependent on the perforin-like protein (perforin-2) encoded by macrophage-expressed gene 1.

Authors:  Ryan McCormack; Lesley R de Armas; Motoaki Shiratsuchi; Jahir E Ramos; Eckhard R Podack
Journal:  J Innate Immun       Date:  2012-12-15       Impact factor: 7.349

9.  Oligodendrocyte susceptibility to injury by T-cell perforin.

Authors:  N J Scolding; J Jones; D A Compston; B P Morgan
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

10.  Eradication of metastatic tumour cells from lymph nodes by local administration of anti-CD3 antibody.

Authors:  Y Dohi; S Sunada; M Aoki; A Moriguchi; M Okabayashi; M Miyata; H Matsuda
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.